All News

A new study from the University of Colorado Boulder suggests that women who experience menopause at age 55 years or later may have significantly better vascular health and a reduced risk of heart attacks and strokes.

A recent study highlights the need to manage chronic hypertension before and during pregnancy to mitigate the heightened risk of severe maternal morbidity associated with preeclampsia.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study found that menopausal hormone therapy is associated with a higher risk of systemic lupus erythematosus and systemic sclerosis, emphasizing the role of female sex hormones in immune-mediated diseases.

The Rural Obstetrics Readiness Act aims to enhance maternal health in rural communities by providing federal grants, training programs, and telehealth services to better manage obstetric emergencies.

A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.

In a recent study, patients of all age categories were less likely to conceive if they had low antimüllerian hormone levels, highlighting its potential in reproductive counseling.

A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.

A new study suggests that fresh embryo transfer may improve live birth rates in women with a low chance of in vitro fertilization success compared to frozen embryo transfer.

Discover how Mirvie’s RNA platform uses a simple blood test to detect fetal growth restriction early in pregnancy, allowing for proactive interventions and improved outcomes for mothers and babies.

Learn how carrier screening and noninvasive prenatal testing help expectant parents identify genetic risks early, explore reproductive options, and prepare for the best possible pregnancy outcomes.

Nicola F. Tavella, MPH, dives into his team's research on postpartum depression and unplanned cesarean delivery, which was presented at SMFM's 2025 Pregnancy Meeting.

Discover the latest advancements in prenatal genetic screening, the challenges preventing access, and how increased awareness can help expecting parents make informed decisions.

Discover how maternal fetal medicine specialists are tackling maternal mortality disparities through trust-building, diverse care teams, and comprehensive support programs.

The FDA-cleared and CLIA-waived cobas liat sexually transmitted infection multiplex assay panels offer rapid, point-of-care testing for chlamydia, gonorrhea, and mycoplasma genitalium.

Timely diagnosis of gestational diabetes is crucial for optimal maternal and fetal health, but a recent study highlights demographic disparities in screening delays and the need for further research on potential health impacts.

A new study links first-trimester hemorrhage and anemia to a higher placenta accreta spectrum risk, emphasizing early screening and non-traditional risk factors.

Learn how complex contraceptive counseling helps individuals with medical conditions such as heart disease, lupus, and breast cancer find safe, effective birth control options tailored to their unique needs.

Daniel L. Kuhr, MD, maternal fetal medicine fellow at Mount Sinai, discusses the role of neighborhood-level indices in predicting spontaneous preterm birth risk and why individual patient characteristics remain the key factor.

A new randomized control trial reveals that barbed sutures significantly reduce blood loss during hysterotomy, offering valuable insights for improving clinical outcomes in obstetric surgery.

Researchers have identified higher concentrations of microplastics and nanoplastics in the placentae of infants born prematurely compared to those born at term, a new study finds.

A new study explores the potential link between antiretroviral therapy, specifically integrase inhibitors, and fetal biometric measurements, shedding light on possible pregnancy complications.

Artificial intelligence-powered ultrasound analysis is enhancing the early detection of congenital heart defects, improving diagnostic accuracy, physician confidence, and neonatal outcomes.

A new study published in Menopause suggests that white blood cell count could serve as a key predictor of COVID-19 symptom severity, highlighting the role of inflammation in health outcomes.

The Mothers and Newborns affected by Opioids - Obstetric initiative significantly increased screening, treatment access, and naloxone counseling for pregnant patients with opioid use disorder, enhancing care and reducing racial disparities.

A recent study found insufficient evidence that oral furosemide reduces the risk of de novo postpartum hypertension, highlighting the need for close monitoring in the first 2 weeks after birth.

A study highlights chronic villitis as a specific placental injury associated with COVID-19, raising concerns about pregnancy complications such as preeclampsia and stillbirth.